Optimization of Substituted N-3-Benzylimidazoquinazolinone Sulfonamides as Potent and Selective PDE5 Inhibitors

Journal of Medicinal Chemistry
2000.0

Abstract

A previous report from these laboratories identified the N-3-benzylimidazoquinazolinone nucleus as a more selective PDE5 inhibitor template compared to the pyrazolopyrimidine of sildenafil. This paper describes in detail the structure-activity relationships of a set of sulfonamide analogues, several of which are both more potent and more selective PDE5 inhibitors in vitro than sildenafil. The synthesis, in vitro enzyme activity and selectivity, and in vitro functional and preclinical pharmacokinetic assessment of molecules in this series are described.

Knowledge Graph

Similar Paper

Optimization of Substituted N-3-Benzylimidazoquinazolinone Sulfonamides as Potent and Selective PDE5 Inhibitors
Journal of Medicinal Chemistry 2000.0
N-3-Substituted Imidazoquinazolinones:  Potent and Selective PDE5 Inhibitors as Potential Agents for Treatment of Erectile Dysfunction
Journal of Medicinal Chemistry 2000.0
Comparison of different heterocyclic scaffolds as substrate analog PDE5 inhibitors
Bioorganic & Medicinal Chemistry Letters 2005.0
Quinolines as extremely potent and selective PDE5 inhibitors as potential agents for treatment of erectile dysfunction
Bioorganic & Medicinal Chemistry Letters 2004.0
Quinazolines as potent and highly selective PDE5 inhibitors as potential therapeutics for male erectile dysfunction
Bioorganic & Medicinal Chemistry Letters 2008.0
2-Phenylquinazolin-4(3H)-one, a class of potent PDE5 inhibitors with high selectivity versus PDE6
Bioorganic & Medicinal Chemistry Letters 2009.0
Synthesis and phosphodiesterase 5 inhibitory activity of new sildenafil analogues containing a phosphonate group in the 5 ′ -sulfonamide moiety of phenyl ring
Bioorganic & Medicinal Chemistry Letters 2004.0
Structure−Activity Relationships of N-Acyl Pyrroloquinolone PDE-5 Inhibitors
Journal of Medicinal Chemistry 2004.0
Furoyl and Benzofuroyl Pyrroloquinolones as Potent and Selective PDE5 Inhibitors for Treatment of Erectile Dysfunction
Journal of Medicinal Chemistry 2003.0
Design, synthesis and evaluation of N2,N4-diaminoquinazoline based inhibitors of phosphodiesterase type 5
Bioorganic & Medicinal Chemistry Letters 2019.0